Search for a command to run...
Public shareholding in Genpharmasec Ltd. has declined by 7.40% YoY and 2.62% QoQ, indicating a lack of retail interest amidst a stagnant institutional and promoter presence.
Both promoters and institutions show no change in shareholding, suggesting a cautious stance from 'smart money' and a potential lack of confidence in the stock's performance.
The sector is also experiencing stagnant conditions, with best performers like SUDARSH.CHEM gaining institutional interest while Genpharmasec Ltd. fails to capture any investor enthusiasm.
| Category | Trend | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|
1Promoter Holdings | 59.96% | 29.98% | 29.98% | 29.98% | 29.98% | 29.98% | 29.98% | 29.98% | |
2Public Holdings | 40.04% | 70.02% | 70.02% | 70.02% | 70.02% | 70.02% | 70.02% | 70.02% | |
3Foreign Investors | - | - | - | - | - | - | - | - | |
4Domestic Investors | - | - | - | - | - | - | - | - |